v2.4.0.8
SEGMENT INFORMATION (Tables)
9 Months Ended
Sep. 30, 2013
SEGMENT INFORMATION  
Schedule of segment information

 

 

(In millions)
  Chlorovinyls   Building
Products
  Aromatics   Eliminations,
Unallocated
and Other
  Total  

Three Months Ended September 30, 2013

                               

Net sales

    $ 750.0     $ 253.4     $ 194.1     $ -     $ 1,197.5  

Intersegment revenues

    $ 61.8     -     -     (61.8 )   $ -  
                       

Total net sales

    $ 811.8     253.4     194.1     (61.8 )   $ 1,197.5  

Long-lived asset impairment charges, net

    $ -     25.8     -     -     $ 25.8  

Transaction related costs and other, net

    $ 1.5     2.9     -     10.4     $ 14.8  

Operating income (loss)

    $ 101.6     (6.7 )   5.2     (22.0 )   $ 78.1  

Depreciation and amortization

    $ 45.7     9.1     0.3     1.7     $ 56.8  

Capital expenditures

    $ 36.0     11.0     2.0     3.9     $ 52.9  

 

                               

Three Months Ended September 30, 2012

                               

Net sales

    $ 329.1     $ 246.2     $ 238.2     $ -     $ 813.5  

Intersegment revenues

    $ 55.7     0.1     -     (55.8 )   $ -  
                       

Total net sales

    $ 384.8     246.3     238.2     (55.8 )   $ 813.5  

Transaction related costs and other, net

    $ 1.3     $ 0.4     -     13.1     $ 14.8  

Gain on sale of assets

    $ (1.9 )   -     -     -     $ (1.9 )

Operating income

    $ 73.8     14.7     11.1     (25.7 )   $ 73.9  

Depreciation and amortization

    $ 11.5     9.9     0.3     1.3     $ 23.0  

Capital expenditures

    $ 7.9     4.7     0.8     1.7     $ 15.1  


 

(In millions)
Chlorovinyls Building
Products
Aromatics Eliminations,
Unallocated
and Other
Total

Nine Months Ended September 30, 2013

Net sales

$ 2,166.3 $ 660.0 $ 705.2 $ - $ 3,531.5

Intersegment revenues

$ 184.8 - - (184.8 ) $ -

Total net sales

$ 2,351.1 660.0 705.2 (184.8 ) $ 3,531.5

Long-lived asset impairment charges, net

$ - 28.4 - - $ 28.4

Transaction related costs and other, net

$ 4.7 2.7 - 26.3 $ 33.7

Operating income (loss)

$ 311.0 (0.9 ) 22.5 (58.7 ) $ 273.9

Depreciation and amortization

$ 124.7 26.5 0.9 5.0 $ 157.1

Capital expenditures

$ 74.9 24.1 3.0 6.5 $ 108.5

Nine Months Ended September 30, 2012

Net sales

$ 998.5 $ 685.8 $ 856.8 $ - $ 2,541.1

Intersegment revenues

$ 194.7 0.4 - (195.1 ) $ -

Total net sales

$ 1,193.2 686.2 856.8 (195.1 ) $ 2,541.1

Long-lived asset impairment charges (recoveries), net

$ - (0.8 ) - - $ (0.8 )

Transaction related costs and other, net

$ 1.3 0.6 - 25.3 $ 27.2

Gain on sale of assets

$ (19.3 ) - - - $ (19.3 )

Operating income

$ 160.2 23.7 46.2 (59.6 ) $ 170.5

Depreciation and amortization

$ 34.0 29.4 1.1 3.5 $ 68.0

Capital expenditures

$ 32.1 15.1 1.8 6.8 $ 55.8
Schedule of sales by product line

 

 

 
  Three Months Ended September 30,   Nine Months Ended September 30,  
(In millions)
  2013   2012   2013   2012  

Chlorovinyls

                         

Chlor-alkali and derivative products

    $ 634.3     $ 218.2     $ 1,806.0     $ 643.1  

Compound products

    115.7     110.9     360.3     355.4  
                   

Total

    750.0     329.1     2,166.3     998.5  
                   

Building Products

                         

Window and door profiles and moulding products

    88.2     85.9     237.4     243.7  

Outdoor building products

    165.2     160.3     422.6     442.1  
                   

Total

    253.4     246.2     660.0     685.8  
                   

Aromatics

                         

Cumene products

    118.8     171.7     451.1     605.1  

Phenol and acetone products

    75.3     66.5     254.1     251.7  
                   

Total

    194.1     238.2     705.2     856.8  
                   

 

                         

Net Sales

    $ 1,197.5     $ 813.5     $ 3,531.5     $ 2,541.1